Showing results (801-810 of 2,003) with videos related to

Sort By:
Pageof 201
Endocrine, Metabolic & Immune Disorders Drug Targets|April 5, 2026
Pathophysiology of CLD: Oxidative Stress and Antioxidant Mechanisms that may Limit its ProgressionPanagiotis Theodosis-Nobelos, Ioanna Papagiouvanni, Adonis A Protopappas, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 13, 2026
Mendelian Randomization Studies of Major Depressive Disorder, Schizophrenia, Bipolar Disorder, and Cancers. A PRISMA Review and Meta-AnalysisElsa Vitale, Lorenza Maistrello, Alessandro Rizzo, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 5, 2026
The Emerging Role of tRNA-Derived Small RNAs (tsRNAs) in Radiation-Induced Cardiovascular PathologyYing Chen, Yunjia Zhu, Lingmei Qian, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 11, 2020
Influence of ESR1 Variants on Clinical Characteristics and Fibromyalgia Syndrome in Turkish WomenHabibe S Arslan, Ayse F Nursal, Ahmet Inanir, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|June 12, 2026
Triglyceride Glycemic Index and Triglyceride/HDL Ratio: Can They be Biomarkers for Insulin Resistance in Euthyroid Women with Hashimoto's Thyroiditis, and Are They Related to Thyroid Function Tests?Seher Çetinkaya Altuntaş, Hande Özgen
Endocrine, Metabolic & Immune Disorders Drug Targets|October 22, 2013
Incretin based therapies: bone protective effectsMarlene Chakhtoura, Sami T Azar
Endocrine, Metabolic & Immune Disorders Drug Targets|June 2, 2026
Study on the Potential Mechanism of Bisphenol A-induced Human Diabetic Nephropathy Based on Network Toxicology and Molecular DockingJiaxin Li, Xiuqin Ni, Qi Fan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|June 2, 2026
Global Research Trends in Innate Lymphoid Cells in the Gut and Kidney: A Bibliometric and Visual AnalysisXing Zhang, Gengxin Liu, Ziyou Yan
Endocrine, Metabolic & Immune Disorders Drug Targets|April 13, 2026
Exploring the Potential Molecular Targets of Cyanidin-3-O-glucoside for Type 2 Diabetes Mellitus TreatmentWenling Yang, Meizhen Wu, Juanlie Luo, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 13, 2026
Stigmasterol, the Active Ingredient in Huanglian Decoction, Inhibits the MAOA-NF-êB-MLCK Pathway to Improve the Inflammation in Rats With Reflux EsophagitisHuan Wang, Lin Li, Jian Han, et al.
Pageof 201